Skip to main content
Funded Studies

Peripheral Blood-based Transcript Biomarkers for Prediction of Parkinson Disease in LRRK2 Mutation Carriers

Objective/Rationale:             
Currently, there is no known marker that can be found in the human blood that can help to predict Parkinson's disease (PD). There is also no marker that can help identify among asymptomatic people who carry a LRRK2 gene mutation (the greatest known genetic contributor to PD) who will convert to PD. We aim to detect such a marker in the blood, based on a specific gene expression pattern.

Project Description: 
An unbiased scan of all sets of RNA molecules in the blood (transcriptome) will be performed using the methodology of massive parallel sequencing (RNASeq). We aim to determine the best RNASeq conditions that will allow meaningful transcriptomic analysis and the identification of low magnitude expression changes. Our analysis will proceed through two stages. First, we will evaluate various sequencing depths using RNA derived from whole cellular blood as well as from white blood cells. Secondly, we will perform a proof-of-concept study to estimate the feasibility of RNA sequencing-based markers in asymptomatic LRRK2 carriers.

Relevance to Diagnosis/Treatment of Parkinson’s Disease:                      
If this feasibility study is successful, a blood marker might be developed that predicts conversion to PD in asymptomatic carriers of the LRRK2 mutation. Such a marker may facilitate therapeutic interventions at a pre-symptomatic disease stage.

Anticipated Outcome:          
Here we propose to develop evidence to prove the concept of a non-invasive, accurate and affordable blood test with the potential to predict the conversion of carriers of LRRK2 mutations from pre-symptomatic stage to full disease. This molecular blood biomarker might also provide insight into disease mechanisms and novel targets for PD therapy.


Researchers

  • Clemens Scherzer, MD

    Boston, MA United States


  • Avi Orr-Urtreger, MD, PhD

    Tel Aviv Israel


Discover More Grants

Search by Related Keywords

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.